Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
iCAD Logo
iCAD Growth Score
45
CB Rank
117167
Heat Score
33
iCAD is a medical technology that offers cancer detection and therapy solutions.
Acquired by
DeepHealth Logo
DeepHealth
Founded
obfuscation
PublicPost-IPO Equity Nashua, New Hampshire, United States51-100 www.icadmed.com
Health Care
Health Diagnostics
Medical Device
Software
Overview

iCAD
Total Funding
obfuscation
Growth Score
45
Heat Score
33

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score45
-5 pts
in past quarter
Heat Score 33
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About iCAD

CB Rank
117167
iCAD is a medical technology that offers cancer detection and therapy solutions.
Acquired by
DeepHealth Logo
DeepHealth
Founded
obfuscation
PublicPost-IPO Equity Nashua, New Hampshire, United States51-100 www.icadmed.com
Health Care
Health Diagnostics
Medical Device
Software

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

  • Photo of Ken Ferry
    Ken Ferry: President & Chief Executive Officer, Board of Directors
    Past Role: Xoft, Chief Executive Officer
  • Photo of Thomas Rusch
    Thomas Rusch: Co-founder
    Past Role: Xoft, Co-Founder & Chief Technology Officer

Details

Sub-Organization of 
DeepHealth Logo
DeepHealth
Legal Name iCAD Inc.
Also Known As Howtek
Operating Status Active
Stock Symbol  NASDAQ:ICAD
Company Type For Profit
Founders  Michael Klein, Thomas Rusch
About the Company
iCAD provides cancer detection and therapy solutions. Their breast health solutions provide software solutions for digital breast tomosynthesis and breast density. Breast cancer solutions also provide tools to support disease detection and analysis.
Phone Number +1 866 280 2239
Contact Email sales@icadmed.com
Diversity Spotlight 
Women Led
Predictions & Insights

Growth Insight

See this Growth Insight
iCAD is
Lorem
 to be growing
Top Contributing Factors
Financial Decline

Products & Services

ProFound AI Detection
An AI-powered solution for early breast cancer detection using 2D and 3D mammography images to identify suspicious lesions and improve diagnostic accuracy.
PowerLook Density Assessment
A tool that objectively assesses and standardizes breast density from mammogram images to inform personalized screening and risk evaluation.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - iCAD Logo
Post-IPO Equity - iCAD
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - iCAD Logo
Post-IPO Equity - iCAD
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - iCAD Logo
Post-IPO Equity - iCAD
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - iCAD Logo
Post-IPO Equity - iCAD
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - iCAD Logo
Post-IPO Equity - iCAD
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - iCAD Logo
Post-IPO Equity - iCAD
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - iCAD Logo
Post-IPO Equity - iCAD
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - iCAD Logo
Post-IPO Equity - iCAD
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - iCAD Logo
Post-IPO Equity - iCAD
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - iCAD Logo
Post-IPO Equity - iCAD
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Deerfield Logo
Deerfield
No
Post-IPO Debt - iCAD Logo
Post-IPO Debt - iCAD
—
Deerfield Logo
Deerfield
No
Post-IPO Debt - iCAD Logo
Post-IPO Debt - iCAD
—
Deerfield Logo
Deerfield
No
Post-IPO Debt - iCAD Logo
Post-IPO Debt - iCAD
—
Deerfield Logo
Deerfield
No
Post-IPO Debt - iCAD Logo
Post-IPO Debt - iCAD
—
Deerfield Logo
Deerfield
No
Post-IPO Debt - iCAD Logo
Post-IPO Debt - iCAD
—

Investments

Number of Acquisitions 7

Investment Breakdown

Number of Acquisitions 7

M&A Details

iCAD was acquired by DeepHealth for
obfuscation
on
obfuscation
. This deal was done in Stock.
Transaction Name 
iCAD acquired by DeepHealth Logo
iCAD acquired by DeepHealth
Acquired by 
DeepHealth Logo
DeepHealth
Announced Date 
obfuscation
Price 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 6 Board Members and Advisors 9 Contacts 107

Employee Profiles

Board Members and Advisors

News

News and Press

News•Apr 17, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 24, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 10, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

2,005
138.41%
 in past month

IT Spend

$1.5MThis year, iCAD is projected to spend $1.5M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Monthly Active Users (MAU) Logo
Monthly Active Users (MAU)
100
Foundry (Modo) Logo
Foundry (Modo)
96
Mixed Reality Logo
Mixed Reality
93

Actively Used Products

20iCAD uses 20 technology products and services including HTML5, Google Cloud Translation API, and  Wordpress, according to G2 Stack.

Active Website Tech Count

20iCAD is actively using 20 technologies for its website, according to BuiltWith. These include HSTS, DNSSEC, and  IPv6.

Total IP

63The intellectual property of iCAD includes 47 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, iCAD has registered 16 trademarks with the most popular class being 'Scientific and electric apparatus and instruments', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is iCAD's headquarters? iCAD is located in Nashua, New Hampshire, United States.Who invested in iCAD? iCAD is funded by Deerfield.When was the last funding round for iCAD? iCAD closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are iCAD's competitors? Alternatives and possible competitors to iCAD may include Subtle Medical, Lunit, and  FathomX.How much funding has iCAD raised to date? iCAD has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3237dbc 1)
|